GLACIER BAN ($GBCI) posted quarterly earnings results on Thursday, April 24th. The company reported earnings of $0.48 per share, missing estimates of $0.48 by $0.00. The company also reported revenue of $222,620,000, beating estimates of $205,850,484 by $16,769,516.
You can see Quiver Quantitative's $GBCI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GLACIER BAN Hedge Fund Activity
We have seen 159 institutional investors add shares of GLACIER BAN stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COOKE & BIELER LP removed 1,017,420 shares (-24.6%) from their portfolio in Q4 2024, for an estimated $51,094,832
- MILLENNIUM MANAGEMENT LLC added 916,163 shares (+4600.1%) to their portfolio in Q4 2024, for an estimated $46,009,705
- UBS GROUP AG added 589,299 shares (+620.4%) to their portfolio in Q4 2024, for an estimated $29,594,595
- STATE STREET CORP added 493,000 shares (+9.5%) to their portfolio in Q4 2024, for an estimated $24,758,460
- DEPRINCE RACE & ZOLLO INC removed 463,835 shares (-24.2%) from their portfolio in Q4 2024, for an estimated $23,293,793
- VICTORY CAPITAL MANAGEMENT INC removed 286,882 shares (-18.7%) from their portfolio in Q4 2024, for an estimated $14,407,214
- JPMORGAN CHASE & CO added 242,414 shares (+76.0%) to their portfolio in Q4 2024, for an estimated $12,174,031
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GLACIER BAN Congressional Stock Trading
Members of Congress have traded $GBCI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GBCI stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 12/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
